 TORONTO, Aug. 27, 2021 PRNewswire - Braxia Scientific Corp. Braxia Scientific, or the Company, CSE: BRAX OTC: BRAXF FWB: 496, today reported that it was served with a class action complaint against the Company, its former CEO and president, for the violation of US federal securities laws. The complaint was filed in the US District Court Central District of California and alleges that the Company and the individual defendants violated ss. 